Corteva, Inc. (NYSE:CTVA) Given Consensus Rating of “Moderate Buy” by Analysts

Corteva, Inc. (NYSE:CTVA) has been assigned an average rating of “Moderate Buy” from the twenty-one brokerages that are covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $82.3158.

A number of equities analysts recently commented on the company. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. Bank of America lifted their price objective on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Rothschild & Co Redburn lowered their target price on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. The Goldman Sachs Group reissued a “buy” rating and issued a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. Finally, Citigroup boosted their price target on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th.

Corteva Trading Up 0.9%

Corteva stock opened at $74.29 on Friday. Corteva has a 1 year low of $53.40 and a 1 year high of $77.41. The firm’s 50 day moving average price is $69.14 and its 200-day moving average price is $68.36. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock has a market cap of $50.20 billion, a P/E ratio of 47.02, a PEG ratio of 2.51 and a beta of 0.75.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. During the same period last year, the company posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts predict that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Institutional Investors Weigh In On Corteva

Several large investors have recently added to or reduced their stakes in CTVA. Norges Bank purchased a new position in shares of Corteva in the 4th quarter worth approximately $504,001,000. Northwestern Mutual Wealth Management Co. lifted its position in Corteva by 6,527.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock worth $211,025,000 after buying an additional 3,100,709 shares during the last quarter. Perpetual Ltd boosted its stake in Corteva by 78,688.5% during the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after buying an additional 2,612,459 shares during the period. Pacer Advisors Inc. increased its position in Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after acquiring an additional 2,382,715 shares during the last quarter. Finally, WCM Investment Management LLC increased its position in Corteva by 29.6% during the second quarter. WCM Investment Management LLC now owns 9,044,706 shares of the company’s stock valued at $672,836,000 after acquiring an additional 2,066,519 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.